Intravenous immunoglobulins in MS: a panacea lacking approval?
Hohlfeld
Reinhard
R
D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000628:therapy; D010956:Plasmapheresis / Q000379:methods
D016756:Immunoglobulins, Intravenous